News Category
Vinhomes is advancing an integrated city-building model that combines residential, commercial, educational, healthcare, and green infrastructure, posi...
NanoViricides has registered its Phase II Ebola trial for NV-387 Oral Gummies in the Pan African Clinical Trials Registry, marking a critical step in ...
NanoViricides is set to begin a Phase II trial of NV-387 Oral Gummies for Ebola in the DRC, potentially offering a more accessible treatment option in...
As the Bundibugyo Ebola outbreak in the DRC escalates, GeoVax offers its MVA-based vaccine candidates and expertise to support global response efforts...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for the Bundibugyo ebolavirus outbreak, potentia...
NanoViricides has submitted an application to begin a Phase II trial of its NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approve...
NanoViricides applies to begin a Phase II trial of its oral antiviral NV-387 for the Bundibugyo ebolavirus outbreak in the DRC, potentially offering a...
NanoViricides received National Ethics Committee approval in the DRC for a Phase II trial of NV-387 oral gummies against Bundibugyo ebolavirus, positi...
The Democratic Republic of Congo’s mining sector has avoided disruptions from the Middle East crisis, maintaining copper and cobalt production growth ...
NanoViricides is progressing its oral gummies formulation of NV-387 toward a Phase II clinical trial for the Bundibugyo ebolavirus outbreak in the Dem...
NanoViricides has shipped its broad-spectrum antiviral candidate NV-387 to the Democratic Republic of Congo for a Phase II clinical trial against MPox...
NanoViricides has received approval from the Democratic Republic of Congo's Pillar Committee to proceed with a Phase II clinical trial of NV-387 Oral ...
Redwood AI Corp. has signed a non-binding letter of intent to develop a regional pathogen tracking and AI-enabled outbreak intelligence initiative in ...
Trident Digital Tech Holdings Ltd. launched TDTHAI, an AI platform for enterprise deployment in Asia-Pacific, marking a strategic move toward AI-enabl...
The U.S. CDC has extended its Ebola-related travel ban to legal permanent residents who have been in Uganda, South Sudan, or the DRC within the past 2...
NanoViricides announces that its broad-spectrum antiviral candidate NV-387 warrants evaluation for the Bundibugyo Ebola outbreak, offering potential a...
NanoViricides emphasizes the potential of its oral drug candidate NV-387 for pandemic preparedness amid the Bundibugyo Ebola outbreak, targeting commo...
NanoViricides reported progress on its broad-spectrum antiviral NV-387, including regulatory approval for Phase II MPox trials in the DRC and FDA orph...
The ongoing Iran war is causing supply disruptions of critical leaching chemicals for cobalt and copper miners in the Democratic Republic of Congo, fo...
NanoViricides announced plans to begin a Phase II clinical trial of its antiviral candidate NV-387 for MPox in the Democratic Republic of Congo, marki...
The acquisition of Chemaf by US-based Virtus Minerals underscores the growing strategic importance of securing critical mineral supply chains for the ...
Easy Environmental Solutions reports strong Q1 2026 momentum, driven by global nitrogen shortages and new deployments of its Terreplenish® microbial s...
NanoViricides announced the completion of manufacturing for its NV-387 Oral Gummies drug product and its upcoming presentation at the NIBA Investment ...
The Democratic Republic of Congo has ended a 10-month ban on cobalt exports, underscoring the risks of concentrated supply chains for critical mineral...
Micropolis AI Robotics (NYSE: MCRP) announced a $9.3 million agreement with AfricAI Limited to develop customized unmanned ground vehicles for African...
NanoViricides president Dr. Anil Diwan discusses the company's nanoviricide platform and lead candidate NV-387, which has shown broad-spectrum efficac...
The Democratic Republic of Congo's suspension of cobalt exports in early 2025 threatens a supply deficit by 2026-2027, impacting industries reliant on...
